ATCvet code QJ51

ATC codes

J Antiinfectives for systemic use

J01 Antibacterials for systemic use

J02 Antimycotics for systemic use

J04 Antimycobacterials

J05 Antivirals for systemic use

Human only

J06 Immune sera and immunoglobulins

J07 Vaccines

ATCvet only

QJ51 Antibacterials for intramammary use

QJ54 Antimycobacterials for intramammary use

ATCvet code QJ51 Antibacterials for intramammary use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products for veterinary use. Subgroup QJ51 is part of the anatomical group QJ Antiinfectives for systemic use.^[1]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

QJ51A Tetracyclines for intramammary use

QJ51AA Tetracyclines

QJ51AA03 Chlortetracycline

QJ51AA06 Oxytetracycline

QJ51AA07 Tetracycline

QJ51AA53 Chlortetracycline, combinations

QJ51B Amphenicols for intramammary use

QJ51BA Amphenicols

QJ51BA01 Chloramphenicol

QJ51BA02 Thiamphenicol

QJ51BA90 Florfenicol

QJ51C Beta-lactam antibacterials, penicillins, for intramammary use

QJ51CA Penicillins with extended spectrum

QJ51CA01 Ampicillin

QJ51CA51 Ampicillin, combinations

QJ51CE Beta-lactamase sensitive penicillins

QJ51CE01 Benzylpenicillin

QJ51CE09 Procaine penicillin

QJ51CE59 Procaine penicillin, combinations

QJ51CE90 Phenetamate

QJ51CF Beta-lactamase resistant penicillins

QJ51CF01 Dicloxacillin

QJ51CF02 Cloxacillin

QJ51CF03 Meticillin

QJ51CF04 Oxacillin

QJ51CF05 Flucloxacillin

QJ51CR Combinations of pencillins and/or beta-lactamase inhibitors

QJ51CR01 Ampicillin and enzyme inhibitor

QJ51CR02 Amoxicillin and enzyme inhibitor

QJ51CR50 Combinations of penicillins

QJ51D Other beta-lactam antibacterials for intramammary use

QJ51E sulfonamides and trimethoprim for intramammary use

QJ51EA Trimethoprim and derivatives

QJ51EA01 Trimethoprim

QJ51F Macrolides and lincosamides for intramammary use

QJ51FA Macrolides

QJ51FA01 Erythromycin

QJ51FA02 Spiramycin

QJ51FA90 Tylosin

QJ51FF Lincosamides

QJ51FF90 Pirlimycin

QJ51G Aminoglycoside antibacterials for intramammary use

QJ51GB Other aminoglycosides

QJ51GB03 Gentamicin

QJ51GB90 Apramycin

QJ51R Combination of antibacterials for intramammary use

QJ51RA Tetracyclines, combinations with other antibacterials

QJ51RA01 Chlortetracycline, combinations with other antibacterials

QJ51RB Amphenicols, combinations with other antibacterials

QJ51RB01 Chloramphenicol, combinations with other antibacterials

QJ51RC Beta-lactam antibacterials, penicillins, combinations with other antibacterials

QJ51RC04 Procaine penicillin, dihydrostreptomycin, sulfadimidin

QJ51RC20 Ampicillin, combinations with other antibacterials

QJ51RC21 Pivampicillin, combinations with other antibacterials

QJ51RC22 Benzylpenicillin, combinations with other antibacterials

QJ51RC23 Procaine penicillin, combinations with other antibacterials

QJ51RC24 Benzathine benzylpenicillin, combinations with other antibacterials

QJ51RC25 Penethamate hydroiodide, combinations with other antibacterials

QJ51RC26 Cloxacillin, combinations with other antibacterials

QJ51RD Other beta-lactam antibacterials, combinations with other antibacterials

QJ51RD01 Cefalexin, combinations with other antibacterials

QJ51RD34 Cefacetrile, combinations with other antibacterials

QJ51RE Sulfonamides and trimethoprim including derivatives

QJ51RE01 Sulfadiazine and trimethoprim

QJ51RF Macrolides and lincosamides, combinations with other antibacterials

QJ51RF01 Spiramycin, combinations with other antibacterials

QJ51RF02 Erythromycin, combinations with other antibacterials

QJ51RF03 Lincomycin, combinations with other antibacterials

QJ51RG Aminoglycoside antibacterials, combinations

QJ51RG01 Neomycin, combinations with other antibacterials

QJ51RV Combinations of antibacterials and other substances

QJ51RV01 Antibacterials and corticosteroids

QJ51RV02 Antibacterials, antimycotics and corticosteroids

QJ51X Other antibacterials for intramammary use

QJ51XX Other antibacterials for intramammary use

QJ51XX01 Rifaximin

References

↑ "ATCvet Index 2016: code QJ51". WHO Collaborating Centre for Drug Statistics Methodology.

Antibacterials: protein synthesis inhibitors (J01A, J01B, J01F, J01G, QJ01XQ)

30S

Aminoglycosides
(initiation inhibitors)

-mycin (Streptomyces)	Streptomycin^# Dihydrostreptomycin Neomycin^# Framycetin Paromomycin Ribostamycin Kanamycin^# Amikacin Arbekacin Bekanamycin Dibekacin Tobramycin Spectinomycin^# Hygromycin B Paromomycin

-micin (Micromonospora)	Gentamicin^# Netilmicin Sisomicin Isepamicin Verdamicin Astromicin

Tetracycline antibiotics
(tRNA binding)

Tetracyclines	Doxycycline^# Chlortetracycline Clomocycline Demeclocycline Lymecycline Meclocycline Metacycline Minocycline Oxytetracycline Penimepicycline Rolitetracycline Tetracycline

Glycylcyclines	Tigecycline

50S

Oxazolidinone
(initiation inhibitors)

Peptidyl transferase

Amphenicols	Chloramphenicol^# Azidamfenicol Thiamphenicol Florfenicol

Pleuromutilins	Retapamulin Tiamulin Valnemulin

MLS (transpeptidation/translocation)

Macrolides	Azithromycin^# Clarithromycin Dirithromycin Erythromycin^# Flurithromycin Josamycin Midecamycin Miocamycin Oleandomycin Rokitamycin Roxithromycin Spiramycin Troleandomycin Tylosin Ketolides Telithromycin Cethromycin Solithromycin^†

Lincosamides	Clindamycin^# Lincomycin Pirlimycin

Streptogramins	Pristinamycin Quinupristin/dalfopristin Virginiamycin

EF-G

Steroid antibacterials	Fusidic acid

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Antibacterials: cell envelope antibiotics (J01C-J01D)

Intracellular

Inhibit peptidoglycan subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
DADAL/AR inhibitors (Cycloserine)
bactoprenol inhibitors (Bacitracin)

Glycopeptide

Inhibit PG chain elongation: Vancomycin^# (Oritavancin
Telavancin)
Teicoplanin (Dalbavancin)
Ramoplanin

β-lactams/
(Inhibit PBP
cross-links)

Penicillins
(Penams)

Narrow Spectrum

β-lactamase Sensitive (1st Generation)	Benzylpenicillin (G)^# Benzathine benzylpenicillin^# Procaine benzylpenicillin^# Phenoxymethylpenicillin (V)^# Propicillin^‡ Pheneticillin^‡ Azidocillin^‡ Clometocillin^‡ Penamecillin^‡

β-lactamase Resistant (2nd Generation)	Cloxacillin^# (Dicloxacillin Flucloxacillin) Oxacillin Nafcillin Methicillin^‡

Extended Spectrum

Aminopenicillins (3rd Generation)	Amoxicillin^# Ampicillin^# (Pivampicillin Hetacillin^‡ Bacampicillin^‡ Metampicillin^‡ Talampicillin^‡) Epicillin^‡

Carboxypenicillins (4th Generation)	Ticarcillin Carbenicillin^‡ / Carindacillin^‡ Temocillin^‡

Ureidopenicillins (4th Generation)	Piperacillin Azlocillin^‡ Mezlocillin^‡

Other	Mecillinam^‡ (Pivmecillinam^‡) Sulbenicillin^‡

Penems

Faropenem^‡

Carbapenems

Cephalosporins/Cephamycins
(Cephems)

1st Generation (P Ec K)	Cefazolin^# Cefalexin ^# Cefadroxil Cefapirin Cefazedone^‡ Cefazaflur^‡ Cefradine^‡ Cefroxadine^‡ Ceftezole^‡ Cefaloglycin^‡ Cefacetrile^‡ Cefalonium^‡ Cefaloridine^‡ Cefalotin^‡ Cefatrizine^‡

2nd Generation (H E N)	Cefaclor Cefotetan Cephamycin (Cefoxitin Cefprozil Cefuroxime Cefuroxime axetil Cefamandole^‡ Cefminox^‡ Cefonicid^‡ Ceforanide^‡ Cefotiam^‡ Cefbuperazone^‡ Cefuzonam^‡ Cefmetazole)^‡ Carbacephem^‡ (Loracarbef^‡)

3rd Generation	Cefixime^# Ceftriaxone^# Antipseudomonal (Ceftazidime^# Cefoperazone) Cefdinir Cefcapene Cefdaloxime Ceftizoxime Cefmenoxime Cefotaxime Cefpiramide Cefpodoxime Ceftibuten Cefditoren Cefetamet^‡ Cefodizime^‡ Cefpimizole^‡ Cefsulodin^‡ Cefteram^‡ Ceftiolene^‡ Oxacephem (Flomoxef^‡ Latamoxef^‡‡)

4th Generation (Pseudomonas)	Cefepime Cefozopran^‡ Cefpirome^‡ Cefquinome^‡

5th Generation	Ceftaroline fosamil Ceftolozane Ceftobiprole^‡

Veterinary	Ceftiofur Cefquinome Cefovecin

Monobactams

β-lactamase Inhibitors

Combinations

Other

polymyxins/detergent
- Colistin
- Polymyxin B
depolarizing
- Daptomycin
Hydrolyze NAM-NAG
- lysozyme
Gramicidin
Isoniazid
Teixobactin

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Antibacterials: nucleic acid inhibitors (J01E, J01M)

Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis)

DHFR inhibitor

2,4-Diaminopyrimidine
- Trimethoprim^#
- Brodimoprim
- Tetroxoprim
- Iclaprim^†

Sulfonamides
(DHPS inhibitor)

Short- acting	Sulfaisodimidine Sulfamethizole Sulfadimidine Sulfapyridine Sulfafurazole Sulfanilamide Prontosil Sulfathiazole Sulfathiourea

Intermediate- acting	Sulfamethoxazole Sulfadiazine^# Sulfamoxole

Long- acting	Sulfadimethoxine Sulfadoxine Sulfalene Sulfametomidine Sulfametoxydiazine Sulfamethoxypyridazine Sulfaperin Sulfamerazine Sulfaphenazole Sulfamazone

Other/ungrouped	Sulfacetamide Sulfadicramide Sulfametrole

Combinations

Trimethoprim/sulfamethoxazole^#

Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication)

1st g.

Fluoro-
quinolones

2nd g.	Ciprofloxacin^# Ofloxacin Enoxacin^‡ Fleroxacin^‡ Lomefloxacin^‡ Nadifloxacin^‡ Norfloxacin^‡ Pefloxacin^‡ Rufloxacin^‡

3rd g.	Levofloxacin Balofloxacin^‡ Grepafloxacin^‡ Pazufloxacin^‡ Sparfloxacin^‡ Temafloxacin^‡ Tosufloxacin^‡

4th g.	Besifloxacin Gatifloxacin Finafloxacin Gemifloxacin Moxifloxacin Clinafloxacin^† Garenoxacin^‡ Prulifloxacin^‡ Sitafloxacin^‡ Trovafloxacin^‡/Alatrofloxacin^‡

Vet.	Danofloxacin Difloxacin Enrofloxacin Ibafloxacin Marbofloxacin Orbifloxacin Pradofloxacin Sarafloxacin

Newer non-fluorinated

Nemonoxacin

Related (DG)

Aminocoumarins: Novobiocin

Anaerobic DNA
inhibitors

Nitro- imidazole derivatives	Metronidazole^# Tinidazole Ornidazole

Nitrofuran derivatives	Nitrofurantoin^# Furazolidone^‡ Nifurtoinol

RNA synthesis

Rifamycins/ RNA polymerase	Rifampicin^# Rifabutin Rifapentine Rifaximin Rifalazil^§

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Antibacterials: others (J01X)

Other/ungrouped	bornane: Xibornol cresol: Clofoctol polyamine: Methenamine alpha hydroxy acid: Mandelic acid nitroquinoline: Nitroxoline pyran/fatty acid: Isoleucine-tRNA ligase inhibitors (Mupirocin)

This article is issued from Wikipedia - version of the Saturday, October 03, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.